Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback